Collaboration

Intensive collaboration with international and domestic research partners is one of the FNUSA-ICRC core activities. Our researchers collaborate with scientists, physicians and other experts from more than one hundred research institutions around the world.

Our center has formal collaboration agreements with a number of renowned foreign institutions such as the Mayo Clinic and with leading universities and research institutes from the Czech Republic as well. FNUSA-ICRC is currently member of seven European research networks and more than ten Horizon 2020 grants.

There is an active exchange of staff with many renowned universities and research centers.

The international character of FNUSA-ICRC is a natural component of FNUSA-ICRC daily activities as almost one fourth of our employees is from abroad. Multidisciplinary approach with international scope is an essential driver of innovation.  This approach is principal key to success especially in health care. Within FNUSA-ICRC there are since January 2018 operating 29 multidisciplinary and international teams and core facilities combined of research from both the Czech Republic and abroad which guarantees very innovative and creative ambience. Only a multidisciplinary team can address complex clinical needs. FNUSA-ICRC is seeking new opportunities for collaborations with globally recognized institutions.

The internationalization and global promotion of FNUSA-ICRC is also actively supported by the Czech Diplomatic Service and by the interaction of FNUSA-ICRC with the Czech Embassies across the world. Thanks to that various kinds of events to raise the awareness of diseases that represent a serious threat for the global society have recently been organized in the USA (Washington, D.C., Chicago, and San Diego).

Beyond our current partnerships with Mayo Clinic and other institutions from all around the world who help us to deliver the best possible results, we are also negotiating new forms of collaborations with institutions from Canada and Japan.

FNUSA-ICRC Collaboration Agreements

USA | CANADA

EUROPE

ASIA

At FNUSA-ICRC, we seek to improve research practices and the clinical care provided to patients also thanks to the collaboration with academic and other professional institutions. We are convinced that a qualitative change in research, health care and quality of life can be attained through the development of strong partnerships enabling true systematic changes to the environment and paying back to the society.

Currently we are creating a unique regional scientific platform for top scientists in Moravia with the impact far beyond the borders of Central Europe. This platform connects FNUSA-ICRC with four major research institutions in the Moravian Region (Institute of Molecular and Translational Medicine at Palackého University in Olomouc – IMTM, the Regional Centre of Applied Molecular Oncology (RECAMO) at Masaryk Memorial Cancer Institute, the Department of Neurology at the Faculty of Medicine, Olomouc University Hospital and the Blood Cancer Research Group at Ostrava University – BCRG). This platform will be created thanks to the Project “Molecular, Cell and Clinical Approach to Healthy Aging” (abbreviated ENOCH), recently approved for a grant from the EU Structural Fund. The main research objective of the project is to formulate a joint research program that is focused on research into aging and age-related diseases, namely cancer, chronic inflammation and degenerative diseases during the implementation project phase from 2018 to 2023.

FNUSA-ICRC Collaboration Agreements within the Czech Republic

BRNO

PRAGUE

OLOMOUC

FNUSA-ICRC is a member of several European research networks:

We are keen to join further relevant research networks – please contact us at icrc@fnusa.cz

Horizon 2020 Grants

FNUSA-ICRC is proud to have participated in more than 10 Horizon 2020 grants and has a fast-increasing number of research grants from many sources, such as the Horizon 2020 program, INTERREG, EU Structural Funds, Grant Agency of the Czech Republic, Technology Agency of the Czech Republic, Agency for Healthcare Research, Czech Ministry of Education, or from the South Moravian Region.  

We are actively seeking further H2020 opportunities and would be interested to join emerging H2020 consortia which are planning to apply for grants in fields of our research.
Should you wish to explore the possibility to apply for a joint grant with us, please contact Head of the Grant Support Center (petr.rychtecky(at)fnusa.cz).

PROJECTS AND GRANTS FNUSA-ICRC

Alliance4Life

Alliance4Life was a strategic project of ten research institutions from nine Central and Eastern European countries. The project aimed to highlight current gaps in health research and to reduce the gap between the innovative performance of new and original members of the European Union.

A4L_Actions
The second H2020 project of the now 13-member Alliance4Life consortium. It is a new continuation of the now formally existing international alliance of leading research institutions and universities operating in the field of biological and medical sciences in the countries of Central and Eastern Europe. Over the next three years, intensive cooperation will be developed to implement a number of examples of good practice, which have already been pilot-tested in the Alliance’s activities to date. The aim of the project is mainly to improve the institutional culture and strategic management of institutions and to be an inspiration for improving the conditions for excellent science in Central and Eastern Europe.

WEB ALLIANCE4LIFE

BEATsep

Our center, specifically the Cellular and Molecular Immunoregulation team of Mgr. Jan Frič, Ph.D., MHA, is from 1.1.2024 the coordinator of the project “Biomarkers established to stratify sepsis long-term adverse effects to improve patients’ health and quality of life (BEATsep)”.
In the Czech Republic, it is one of three projects coordinated under the Research and Innovation Action (RIA) category of the Horizon Europe Health Programme. Mgr. Jan Frič, Ph.D., MHA and Mgr. Marcela Hortová Kohoutková, Ph.D. have formed a consortium of 11 partners across 6 European countries with a total budget of EUR 6,9 million for a period of five years (of which EUR 1,8 million for the coordinating institution – our ICRC). The main goal of the project is to research the long-term consequences of sepsis: “We want to portray in detail the condition of a patient with sepsis, to better understand the changes that persist in the body in the long term, and to look for combinations of suitable biomarkers from which it will be possible to predict how the patient’s condition will further develop, and thus better determine tailored treatment,” explained project coordinators Jan Frič and Marcela Hortová Kohoutková.